Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00475332 · ClinicalTrials.gov registry record · Phase 2
Study to Treat Relapsed Follicular Non-Hodgkin's Lymphoma With Radiation and Bexxar
A Phase 2 study, sponsored by University of Florida.
- Terminated
- Registry status
- Phase 2
- Development phase
- 2
- Enrollment target
NCT00475332: Clinical Trial Phase 2 study, sponsored by University of Florida.
NCT00475332 is a Phase 2 study that was terminated before completion, run by University of Florida. The registered enrollment target is 2 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00475332, a Phase 2 study, was terminated before completion, sponsored by University of Florida.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 2 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the feasibility of treating relapsed follicular lymphoma with a combination of Bexxar and External Beam Radiotherapy (EBRT). Patients will receive EBRT (20 Gy in 10 fractions) followed by Bexxar.
Primary Outcome
13 patients will be enrolled initially and followed for 3 months. If less than 10 of these patients reach a grade III or IV toxicity, then 12 more patients will be enrolled and the study will be deemed feasible. If 11 or more of the first group experience grade III/IV toxicity, the trial will stop early.
Interventions
- PROCEDURE External Beam Radiation Therapy
- DRUG Iodine I -01 Tositumomab (Bexxar)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2007-09 |
| Est. Completion | 2009-04 |
| Phase | Phase 2 |
Why NCT00475332 stopped before completion
NCT00475332 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which External Beam Radiation Therapy is the first listed.
NCT00475332 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00475332 about?
NCT00475332 is a clinical study titled "Study to Treat Relapsed Follicular Non-Hodgkin's Lymphoma With Radiation and Bexxar". The purpose of this study is to determine the feasibility of treating relapsed follicular lymphoma with a combination of Bexxar and External Beam Radiotherapy (EBRT). Patients will receive EBRT (20 Gy in 10 fractions) followed by Bexxar.
What is the current status of trial NCT00475332?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 2 participants. The study started on 2007-09. Estimated completion is 2009-04.
What interventions are being tested in trial NCT00475332?
The interventions under investigation include: External Beam Radiation Therapy (PROCEDURE), Iodine I -01 Tositumomab (Bexxar) (DRUG).
Who is sponsoring clinical trial NCT00475332?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00475332's enrollment target sits among peer trials
2 2001st of 2000 the lowest of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia